The Primary
Care Companionfor CNS Disorders

Academic Highlights December 15, 2004

Enhancement of Treatment Response in Depression in the Primary Care Setting

Prim Care Companion J Clin Psychiatry 2004;6(6):253-261

Article Abstract

Click to enlarge page

Academic Highlights Antidepressants Depression

View Related Activity

Go to Activity

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 27 • 2025 • Number 1

Read the Current Issue

Rounds in the General Hospital

Psychosis-Related PTSD

Case Report

Thyrotoxic Psychosis in Graves’ Disease

Case Report

Factitious Disorder in the Context of Abuse in an Adolescent

Rounds in the General Hospital

Wishing That Your Patient Would Die: Reasons and Reactions

Case Report

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Case Report

Low-Dose Clozapine in Schizophrenia With Aggression

View current Issue

Academic Highlights

Dysregulation of Noradrenergic Activity

November 8, 2024

Dysregulation of noradrenergic activity plays a key role in symptom presentation in major depressive disorder, schizophrenia, Alzheimer’s agitation, and PTSD. This article provides an expert panel’s consensus regarding the...

Rakesh Jain , Craig Chepke , Lori L. Davis , et al

Academic Highlights

Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...

Christoph U. Correll , Zahinoor Ismail , Roger S. McIntyre , et al

Academic Highlights

The Differential Diagnosis of MDD Versus BP

May 14, 2019

Roger S. McIntyre , Mark Zimmerman , Joseph F. Goldberg , et al

Enhancement of Treatment Response in Depression in the Primary Care Setting

Read the Current Issue

Psychosis-Related PTSD

Thyrotoxic Psychosis in Graves’ Disease

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

ELSEWHERE:

FOLLOW US:

Enhancement of Treatment Response in Depression in the Primary Care Setting

Read the Current Issue

Psychosis-Related PTSD

Thyrotoxic Psychosis in Graves’ Disease

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

Related Articles

Dysregulation of Noradrenergic Activity

Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder

The Differential Diagnosis of MDD Versus BP

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles